Pharmaceutical Manufacturing
Nightfood Holdings Signs Strategic Automation Agreement with Taiwan Engineering Company
Nightfood Holdings, doing business as TechForce Robotics, has signed a strategic supply and development agreement with Taiwan's Jiun Jiang Enterprise to advance its AI-enhanced automation platform, targeting growth in semiconductor, pharmaceutical, and laboratory automation.
Onco-Innovations Advances Manufacturing Process for Cancer Drug Candidate ONC010
Onco-Innovations Limited has initiated process development and scale-up for ONC010's active ingredient, a key step toward regulatory studies and clinical trials.
Onco-Innovations Advances Manufacturing Scale-Up for Lead Cancer Drug Candidate ONC010
Onco-Innovations Limited reports progress in intermediate-scale manufacturing for its nanoparticle-formulated oncology candidate ONC010, moving it closer to clinical trials in Australia.
Scinai Immunotherapeutics Appoints Eilon Elmalem as Head of Yavne CDMO Facility, Signaling Expansion in Contract Manufacturing
Scinai Immunotherapeutics appoints Eilon Elmalem as site head of its Yavne CDMO facility, underscoring the company's commitment to expanding its contract development and manufacturing platform.
GeoVax Highlights Need for Domestic MVA Vaccine Infrastructure Amid Global Outbreaks
As WHO declares Ebola a public health emergency and mpox spreads, GeoVax emphasizes the strategic importance of scalable U.S.-based MVA manufacturing for biodefense.
Oncotelic Therapeutics Pivots to AI-Robotics, Partners with TechForce for GMP Automation
Oncotelic Therapeutics (OTLC) expands beyond biotech into AI-driven industrial automation through a strategic partnership with TechForce Robotics, commercializing a GMP-compliant robotics platform that leverages its PDAOAI technology.
Maison Luxe Eyes International Expansion with Greek Production Facility Acquisition
Maison Luxe, Inc. is reviewing a potential acquisition of a pharmaceutical-grade production facility in Greece as part of its strategic growth plan to scale operations and enter regulated international markets.
Quantumzyme Expands AI Enzyme Platform to Transform Pharmaceutical Manufacturing
Quantumzyme Corp. is expanding its AI-driven enzyme engineering platform to develop sustainable manufacturing processes for multiple high-volume pharmaceutical ingredients, potentially reducing hazardous waste and carbon emissions in the $300 billion global API market.
Quantumzyme Advances Sustainable Pharmaceutical Manufacturing with International Patent Publications
Quantumzyme's newly announced international patents for enzymatic ibuprofen synthesis represent a significant advancement in green pharmaceutical manufacturing that could reduce chemical waste and improve production efficiency.
GeoVax Advances U.S. Mpox Vaccine Production Amid California Clade 1 Outbreak
The emergence of locally transmitted Clade 1 mpox cases in California highlights critical vulnerabilities in America's single-source vaccine supply chain, prompting GeoVax to accelerate development of domestic manufacturing capabilities with EMA-endorsed regulatory pathways.
Quantumzyme Corp. Secures Patent for Sustainable Ibuprofen Manufacturing Process
Quantumzyme Corp. has achieved a significant milestone with the USPTO publication of its patent for an enzymatic ibuprofen synthesis method, representing a major advancement in sustainable pharmaceutical manufacturing.
Nutriband Advances AVERSA™ Fentanyl Patch Toward FDA Submission with Scaled Manufacturing
Nutriband Inc. has scaled manufacturing for its abuse-deterrent fentanyl patch AVERSA™ through collaboration with Kindeva, positioning the company for FDA submission and potential global commercialization with established patent protection across multiple regions.
Branded Legacy Subsidiary Acquires Vancouver Facility to Expand Addiction Treatment Capabilities
Branded Legacy's subsidiary BioLegacy Evaluative Group has acquired a 22,000-square-foot GMP-compliant facility in Vancouver to develop addiction treatment technologies and harm reduction products, positioning the company to address the local drug crisis through academic partnerships and advanced manufacturing.
BioKey Positions Itself as a Strategic U.S. Pharmaceutical Platform Amid Global Tariff Shifts
ABVC BioPharma's subsidiary, BioKey, leverages its Silicon Valley manufacturing facility to meet global demand for compliant drug production, highlighting the importance of local infrastructure in the face of increasing tariffs and supply chain realignments.
GeoVax Calls for Urgent Investment in Domestic Vaccine Manufacturing Amid Global Health Threats
GeoVax Labs emphasizes the critical need for U.S. investment in domestic vaccine production and diversification to address the vulnerabilities exposed by global health crises like Mpox and COVID-19 variants.
AstraZeneca's $50 Billion Virginia Investment Highlights Maryland's Missed Opportunities
AstraZeneca's decision to build its largest manufacturing facility in Virginia, bypassing Maryland, underscores the latter's challenges in attracting major biopharma investments despite its strong sector presence.
Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase IIb Trials
Oragenics Inc. has partnered with Sterling Pharma Solutions for the GMP production of its concussion drug candidate, ONP-002, marking a significant step towards Phase IIb trials and underscoring the importance of domestic manufacturing in clinical development.
Nutriband Inc. Advances Aversa Fentanyl to Commercial Manufacturing Scale with Kindeva
Nutriband Inc. and Kindeva have successfully scaled up the commercial manufacturing process for Aversa Fentanyl, an abuse-deterrent opioid patch, marking a significant step towards addressing the opioid crisis with innovative technology.
Senate Bipartisan Initiative Aims to Revitalize U.S. Vaccine Manufacturing Capabilities
GeoVax Labs supports a Senate initiative to onshore critical medical manufacturing, highlighting the national push to rebuild domestic vaccine production and enhance public health preparedness through innovative MVA vaccine platforms.
GeoVax Joins EQUIP-A-Pharma Initiative to Boost Domestic Vaccine Manufacturing
GeoVax Labs is positioned to support a new U.S. government initiative aimed at transforming pharmaceutical manufacturing through artificial intelligence and advanced production technologies, with a focus on improving national biodefense and supply chain resilience.
GeoVax Supports White House Initiative to Strengthen Domestic Pharmaceutical Manufacturing
GeoVax Labs has endorsed a recent White House Executive Order aimed at restoring U.S. pharmaceutical manufacturing independence, highlighting the company's advanced vaccine production technology that addresses national biosecurity goals.